Kexing Biopharm Co., Ltd.

This study tests a new growth hormone medicine (GB06) in about 192 children aged 3 to 11 who have growth hormone deficiency, meaning they grow slower than normal. The medicine is given as a daily shot for 52 weeks to see if it helps children grow as well as the current standard t…

This early-stage study tests a new drug called GB18 in people with advanced cancer who are losing weight and muscle (cachexia). The drug targets a protein linked to appetite loss. About 18 to 36 adults will receive multiple doses to see if it is safe and helps them gain weight an…